(5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione
C101H97N25O22S2 — CID 158970681
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione
(5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione (PubChem CID 158970681) has the molecular formula C101H97N25O22S2 and a molecular weight of 2077.17 g/mol. Its IUPAC name is (5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione.
Molecular Properties
| Compound Name | (5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione |
|---|---|
| PubChem CID | 158970681 |
| Molecular Formula | C101H97N25O22S2 |
| Molecular Weight | 2077.17 g/mol |
| Exact Mass | 2075.67 |
| IUPAC Name | (5R)-5-[4-(2-amino-1,3-thiazol-4-yl)phenyl]-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[4-[2-(methylamino)-1,3-thiazol-4-yl]phenyl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3R)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[1-[(3S)-oxolan-3-yl]pyrazol-4-yl]imidazolidine-2,4-dione;(5R)-5-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-(1H-pyrazol-4-yl)imidazolidine-2,4-dione |
| SMILES | CNc1nc(-c2ccc([C@]3(CN4Cc5ccc(OC)cc5C4=O)NC(=O)NC3=O)cc2)cs1.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3ccc(-c4csc(N)n4)cc3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cn[nH]c3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cnn([C@@H]4CCOC4)c3)NC(=O)NC1=O)C2.COc1ccc2c(c1)C(=O)N(C[C@@]1(c3cnn([C@H]4CCOC4)c3)NC(=O)NC1=O)C2 |
| InChI | InChI=1S/C23H21N5O4S.C22H19N5O4S.2C20H21N5O5.C16H15N5O4/c1-24-22-25-18(11-33-22)13-3-6-15(7-4-13)23(20(30)26-21(31)27-23)12-28-10-14-5-8-16(32-2)9-17(14)19(28)29;1-31-15-7-4-13-9-27(18(28)16(13)8-15)11-22(19(29)25-21(30)26-22)14-5-2-12(3-6-14)17-10-32-20(23)24-17;2*1-29-15-3-2-12-8-24(17(26)16(12)6-15)11-20(18(27)22-19(28)23-20)13-7-21-25(9-13)14-4-5-30-10-14;1-25-11-3-2-9-7-21(13(22)12(9)4-11)8-16(10-5-17-18-6-10)14(23)19-15(24)20-16/h3-9,11H,10,12H2,1-2H3,(H,24,25)(H2,26,27,30,31);2-8,10H,9,11H2,1H3,(H2,23,24)(H2,25,26,29,30);2*2-3,6-7,9,14H,4-5,8,10-11H2,1H3,(H2,22,23,27,28);2-6H,7-8H2,1H3,(H,17,18)(H2,19,20,23,24)/t23-;22-;14-,20+;14-,20-;16-/m00100/s1 |
| InChIKey | JNTVLOMFVOPIMA-JKEFTQPJSA-N |
| XLogP | 5.84 |
| TPSA | 585.31 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 150 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2077.17 |
| LogP ≤ 5 | 5.84 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'hydantoin', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158970681 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.